Kabra Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/09/2025 ,inter alia, to consider and approve Notice is hereby given that a meeting ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kabra Drugs Ltd has informed BSE that its Board of Directors will meet on Tuesday, September 2, 2025 at 5:00 PM. Key agenda items include approval of the Director's Report and Corporate Governance Report for FY 2024-25, fixing the AGM date/time/venue, approving the shareholder cut-off date for e-voting, and appointing Internal Auditors for FY 2025-26. The Board will also discuss acquiring new property for office purposes and appoint a scrutinizer for the AGM. The Register of Members and Share Transfer Books will be closed for the AGM.
This is a routine pre-AGM board meeting notice with no immediate material impact on the stock. The discussion around acquiring a new office property is a minor operational matter worth tracking but unlikely to move the share price significantly.